Position in NAMS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$871,684
+$48,355 QoQ
Shares Held
25,721
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#115
of 197 holders
Holding Since
Mar 2026
2 quarters on record
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eleva Capital SAS holds $3,708,141 across 7 Biotechnology names. NAMS ranks #1 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
25,721 | $871,684 | |
| 2 | EWTX |
Edgewise Therapeutics, Inc.
|
17,460 | $709,399 | |
| 3 | CGON |
CG Oncology, Inc.
|
8,289 | $588,933 | |
| 4 | FENC |
Fennec Pharmaceuticals Inc.
|
53,234 | $572,265 | |
| 5 | MLYS |
Mineralys Therapeutics, Inc.
|
17,081 | $460,845 | |
| 6 | IRON |
Disc Medicine, Inc.
|
5,115 | $374,111 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
7,126 | $130,904 |
All Filings in NAMS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $871,684 | 25,721 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $823,329 | 25,721 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||